Patents by Inventor Richard SYGALL

Richard SYGALL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9877945
    Abstract: The present invention refers to the use of a glycerol ester composition of at least one short chain fatty acid for preventing and/or alleviating necrotic enteritis in the gastric tract of galloanserans. The glycerol ester composition comprises at least 75% by weight of glyceryl tributyrate, below 25% by weight of glyceryl dibutyrate and below 8% by weight of glyceryl monobutyrate. The present invention also refers to the use of the glycerol ester composition for modulating the gut flora of galloanserans.
    Type: Grant
    Filed: September 30, 2016
    Date of Patent: January 30, 2018
    Assignee: PERSTORP AB
    Inventors: Filip Van Immerseel, Richard Sygall, Karolien Van Driessche, Richard Ducatelle, Conrad Gerard Schwarzer
  • Publication number: 20170087115
    Abstract: The present invention refers to the use of a glycerol ester composition of at least one short chain fatty acid for preventing and/or alleviating necrotic enteritis in the gastric tract of galloanserans. The glycerol ester composition comprises at least 75% by weight of glyceryl tributyrate, below 25% by weight of glyceryl dibutyrate and below 8% by weight of glyceryl monobutyrate. The present invention also refers to the use of the glycerol ester composition for modulating the gut flora of galloanserans.
    Type: Application
    Filed: September 30, 2016
    Publication date: March 30, 2017
    Applicant: PERSTORP AB
    Inventors: Filip Van IMMERSEEL, Richard SYGALL, Karolien Van DRIESSCHE, Richard DUCATELLE, Conrad Gerard SCHWARZER
  • Publication number: 20160256426
    Abstract: The present invention refers to the use of a glycerol ester composition of at least one short chain fatty acid for preventing and/or alleviating necrotic enteritis in the gastric tract of galloanserans. The glycerol ester composition comprises at least 75% by weight of glyceryl tributyrate, below 25% by weight of glyceryl dibutyrate and below 8% by weight of glyceryl monobutyrate. The present invention also refers to the use of said composition for modulating the gut flora of galloanserans.
    Type: Application
    Filed: October 6, 2014
    Publication date: September 8, 2016
    Applicant: Perstorp AB
    Inventors: Filip Van IMMERSEEL, Richard SYGALL, Karolien Van DRIESSCHE, Richard DUCATELLE, Conrad Gerard SCHWARZER